Welcome to BioMarket Group!

Drugs

In this section you will find Drugs market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

Items 1 to 15 of 51 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4

Set Ascending Direction
  1. Lymphoma Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 383 companies plus partners who are today developing 568 lymphoma drugs in 1073 developmental projects in cancer across 302 different targets. In addition, there are 4 suspended drugs and another 143 drugs where development has been ceased. Learn More

  2. Wnt Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 228 companies plus partners who are today developing 253 Wnt pathway targeting drugs in 935 developmental projects in cancer across 204 different targets. In addition, there are 2 suspended drugs and another 118 drugs where development has been ceased. Learn More

  3. Neuroendocrine Tumors Drug Pipeline Update

    $1,495.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 121 companies plus partners who are today developing 138 neuroendocrine tumor drugs in 199 developmental projects in cancer across 122 different targets. In addition, there is 1 suspended drug and another 24 drugs where development has been ceased. Learn More

  4. Hedgehog Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 163 companies plus partners who are today developing 203 Hedgehog pathway targeting drugs in 883 developmental projects in cancer across 133 different targets. In addition, there are 3 suspended drugs and another 90 drugs where development has been ceased. Learn More

  5. Brain Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 333 companies plus partners who are today developing 397 drugs targeting brain cancer in development. across 225 different targets. In addition, there are 2 suspended drugs and another 96 drugs where development has been ceased. Learn More

  6. Angiogenesis in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 389 companies plus partners who are today developing 428 angiogenesis drugs in 1991 developmental projects in cancer across 288 different targets. In addition, there are 7 suspended drugs and another 218 drugs where development has been ceased. Learn More

  7. Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 378 companies plus partners who are today developing 534 Alpha6Beta4 integrin pathway targeting drugs in 1796 developmental projects in cancer across 186 different targets. In addition, there is 1 suspended drug and another 209 drugs where development has been ceased. Learn More

  8. Pancreatic Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 385 companies plus partners who are today developing 444 drugs targeting pancreatic cancer in development. across 352 different targets. In addition, there is 1 suspended drug and another 136 drugs where development has been ceased. Learn More

  9. IL-7 Signaling Pathway in Oncology Drug Pipeline Update

    $750.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 90 companies plus partners who are today developing 95 IL-7 pathway targeting drugs in 389 developmental projects in cancer across 85 different targets. In addition, there is 1 suspended drug and another 36 drugs where development has been ceased. Learn More

  10. Colorectal Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 426 companies plus partners who are today developing 509 drugs targeting colorectal cancer in development. across 346 different targets. In addition, there are 6 suspended drugs and another 211 drugs where development has been ceased. Learn More

  11. TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 396 companies plus partners who are today developing 509 TGF-beta receptor pathway targeting drugs in 1845 developmental projects in cancer across 259 different targets. In addition, there are 2 suspended drugs and another 265 drugs where development has been ceased. Learn More

  12. Renal Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 243 companies plus partners who are today developing 270 drugs targeting renal cancer in development. across 233 different targets. In addition, there are 3 suspended drugs and another 95 drugs where development has been ceased. Learn More

  13. IL-5 Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 163 companies plus partners who are today developing 209 IL-5 pathway targeting drugs in 891 developmental projects in cancer across 146 different targets. In addition, there are 2 suspended drugs and another 86 drugs where development has been ceased. Learn More

  14. Biologicals in Oncology Drug Pipeline Update

    $3,675.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 1371 companies plus partners who are today developing 2823 biological drugs in 6088 developmental projects in cancer across 801 different targets. In addition, there are 25 suspended drugs and another 1050 drugs where development has been ceased. Learn More

  15. Melanoma Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 374 companies plus partners who are today developing 403 drugs targeting melanoma in development. across 317 different targets. In addition, there are 2 suspended drugs and another 155 drugs where development has been ceased. Learn More

Items 1 to 15 of 51 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4

Set Ascending Direction

Drugs

In this section you will find Drugs market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

Items 1 to 15 of 51 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4

Set Ascending Direction
  1. Lymphoma Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 383 companies plus partners who are today developing 568 lymphoma drugs in 1073 developmental projects in cancer across 302 different targets. In addition, there are 4 suspended drugs and another 143 drugs where development has been ceased. Learn More

  2. Wnt Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 228 companies plus partners who are today developing 253 Wnt pathway targeting drugs in 935 developmental projects in cancer across 204 different targets. In addition, there are 2 suspended drugs and another 118 drugs where development has been ceased. Learn More

  3. Neuroendocrine Tumors Drug Pipeline Update

    $1,495.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 121 companies plus partners who are today developing 138 neuroendocrine tumor drugs in 199 developmental projects in cancer across 122 different targets. In addition, there is 1 suspended drug and another 24 drugs where development has been ceased. Learn More

  4. Hedgehog Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 163 companies plus partners who are today developing 203 Hedgehog pathway targeting drugs in 883 developmental projects in cancer across 133 different targets. In addition, there are 3 suspended drugs and another 90 drugs where development has been ceased. Learn More

  5. Brain Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 333 companies plus partners who are today developing 397 drugs targeting brain cancer in development. across 225 different targets. In addition, there are 2 suspended drugs and another 96 drugs where development has been ceased. Learn More

  6. Angiogenesis in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 389 companies plus partners who are today developing 428 angiogenesis drugs in 1991 developmental projects in cancer across 288 different targets. In addition, there are 7 suspended drugs and another 218 drugs where development has been ceased. Learn More

  7. Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 378 companies plus partners who are today developing 534 Alpha6Beta4 integrin pathway targeting drugs in 1796 developmental projects in cancer across 186 different targets. In addition, there is 1 suspended drug and another 209 drugs where development has been ceased. Learn More

  8. Pancreatic Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 385 companies plus partners who are today developing 444 drugs targeting pancreatic cancer in development. across 352 different targets. In addition, there is 1 suspended drug and another 136 drugs where development has been ceased. Learn More

  9. IL-7 Signaling Pathway in Oncology Drug Pipeline Update

    $750.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 90 companies plus partners who are today developing 95 IL-7 pathway targeting drugs in 389 developmental projects in cancer across 85 different targets. In addition, there is 1 suspended drug and another 36 drugs where development has been ceased. Learn More

  10. Colorectal Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 426 companies plus partners who are today developing 509 drugs targeting colorectal cancer in development. across 346 different targets. In addition, there are 6 suspended drugs and another 211 drugs where development has been ceased. Learn More

  11. TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 396 companies plus partners who are today developing 509 TGF-beta receptor pathway targeting drugs in 1845 developmental projects in cancer across 259 different targets. In addition, there are 2 suspended drugs and another 265 drugs where development has been ceased. Learn More

  12. Renal Cancer Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 243 companies plus partners who are today developing 270 drugs targeting renal cancer in development. across 233 different targets. In addition, there are 3 suspended drugs and another 95 drugs where development has been ceased. Learn More

  13. IL-5 Signaling Pathway in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 163 companies plus partners who are today developing 209 IL-5 pathway targeting drugs in 891 developmental projects in cancer across 146 different targets. In addition, there are 2 suspended drugs and another 86 drugs where development has been ceased. Learn More

  14. Biologicals in Oncology Drug Pipeline Update

    $3,675.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 1371 companies plus partners who are today developing 2823 biological drugs in 6088 developmental projects in cancer across 801 different targets. In addition, there are 25 suspended drugs and another 1050 drugs where development has been ceased. Learn More

  15. Melanoma Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 374 companies plus partners who are today developing 403 drugs targeting melanoma in development. across 317 different targets. In addition, there are 2 suspended drugs and another 155 drugs where development has been ceased. Learn More

Items 1 to 15 of 51 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4

Set Ascending Direction